Integrating HPV Vaccination Into HIV Care Services for Adolescent Girls Living With HIV in Zambia

Friday, November 13, 2026 12:00 AM

Conditions: HPV; Human Papilloma Virus (HPV); HPV Vaccination; HIV Interventions: Behavioral: HPV-HIV integration training and Audit & Feedback support Sponsors: Washington University School of Medicine; National Cancer Institute (NCI) Not yet recruiting

Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort Study

Thursday, November 12, 2026 12:00 AM

Conditions: IgA Nephropathy (IgAN); IgA Vasculitis; Idiopathic Immune Complex Glomerulonephritis; C3 Glomerulopathy; Membranous Nephropathy; Focal and Segmental Glomerulosclerosis; Minimal Change Disease; Anti-Neutrophilic Cytoplasmic ...

Investigating ELSI Issues That May Facilitate or Impede Clinical Translation of Epigenetic Research.

Thursday, November 12, 2026 12:00 AM

Conditions: Healthy Interventions: Behavioral: Analogy Video; Behavioral: Epigenetics Video Sponsors: Washington University School of Medicine; National Institute of Environmental Health Sciences (NIEHS) Not yet recruiting

Medically Tailored Meals to Improve Cancer Outcomes

Thursday, November 12, 2026 12:00 AM

Conditions: Cancer; Healthy Eating Interventions: Dietary Supplement: Medically Tailored Meals; Behavioral: Nutrition Education Sponsors: Washington University School of Medicine; National Cancer Institute (NCI); Food Outreach Recruiting

PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite)

Thursday, November 12, 2026 12:00 AM

Conditions: Carotid Atherosclerosis; Carotid Artery Stenosis Asymptomatic; Asymptomatic Carotid Artery Stenosis Interventions: Drug: 64Cu-NODAGA-CANF; Drug: Optimal Medical Therapy (OMT); Procedure: Carotid Endarterectomy (CEA) surgery Sponsors: ...

Age-Associated Differences in Germinal Center Responses to Influenza and Rabies Vaccination in Humans

Tuesday, November 3, 2026 12:00 AM

Conditions: Healthy Adult Participants; Age 65 and Older; Age 18 to 40; Immunology Interventions: Biological: Trivalent inactivated influenza vaccine; Biological: RabAvert Sponsors: Washington University School of Medicine; National Institute ...

Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer

Tuesday, November 3, 2026 12:00 AM

Conditions: Triple Negative Breast Cancer; Triple Negative Breast Cancer (TNBC); Breast Cancer Interventions: Drug: Dexamethasone; Drug: Famotidine; Drug: Diphenhydramine; Drug: Olanzapine; Drug: Paclitaxel; Drug: Carboplatin; Biological: ...

Multicenter Study for External Validation of the TB-NET Score

Thursday, November 12, 2026 12:00 AM

Conditions: Tumor Burden; Neuroendocrine (NE) Tumors Sponsors: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; University of Lausanne Hospitals; Dana-Farber Cancer Institute; Royal North Shore Hospital; Hacettepe University; ...